相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Tertiary lymphoid structures in cancer
Ton N. Schumacher et al.
SCIENCE (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer
Moran Yang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Therapeutic Targeting of checkpoint Receptors within the DnAM1 Axis
Zoya Alteber et al.
CANCER DISCOVERY (2021)
The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer
William Freed-Pastor et al.
CANCER CELL (2021)
Ovarian Cancer Immunotherapy and Personalized Medicine
Susan Morand et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Immunotherapy in ovarian cancer: we are not there yet
Emma Barber et al.
LANCET ONCOLOGY (2021)
Targeting FAK in anticancer combination therapies
John C. Dawson et al.
NATURE REVIEWS CANCER (2021)
Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer
Shuang Zhang et al.
CANCER DISCOVERY (2021)
Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunothrapy
Sonia Iyer et al.
CANCER DISCOVERY (2021)
Directing Traffic: How to Effectively Drive T Cells into Tumors
Annabelle J. Anandappa et al.
CANCER DISCOVERY (2020)
T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity
Marta Canel et al.
ELIFE (2020)
The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers
Julian Smazynski et al.
GYNECOLOGIC ONCOLOGY (2020)
Cancer associated fibroblast FAK regulates malignant cell metabolism
Fevzi Demircioglu et al.
NATURE COMMUNICATIONS (2020)
FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
Sonia Zaghdoudi et al.
EMBO MOLECULAR MEDICINE (2020)
Antibody engineers seek optimal drug targeting TIGIT checkpoint
Elie Dolgin
NATURE BIOTECHNOLOGY (2020)
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
Denarda Dangaj et al.
CANCER CELL (2019)
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
Carlos J. Diaz Osterman et al.
ELIFE (2019)
Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma
Lei Wu et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Tertiary lymphoid structures in the era of cancer immunotherapy
Catherine Sautes-Fridman et al.
NATURE REVIEWS CANCER (2019)
Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity
Karen O. Dixon et al.
JOURNAL OF IMMUNOLOGY (2018)
Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity
Victor H. Engelhard et al.
JOURNAL OF IMMUNOLOGY (2018)
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Qing Zhang et al.
NATURE IMMUNOLOGY (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
A Critical need for Better Cancer Immunotherapy Models: Are Organotypic Tumor spheroid Cultures the Answer?
Justin M. Balko et al.
CANCER DISCOVERY (2018)
TIGIT: a novel immunotherapy target moving from bench to bedside
Benjamin L. Solomon et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Topography of cancer-associated immune cells in human solid tumors
Jakob Nikolas Kather et al.
ELIFE (2018)
Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
Curtis W. McCloskey et al.
CANCERS (2018)
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
Ellen L. Goode et al.
JAMA ONCOLOGY (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
CD155, an onco-immunologic molecule in human tumors
Jian Gao et al.
CANCER SCIENCE (2017)
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Hui Zhang et al.
CELL (2016)
Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer
David R. Kroeger et al.
CLINICAL CANCER RESEARCH (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
Hanane Laklai et al.
NATURE MEDICINE (2016)
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang et al.
NATURE MEDICINE (2016)
Ovarian cancer
Ursula A. Matulonis et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Tumor infiltrating lymphocytes in ovarian cancer
Phillip P. Santoiemma et al.
CANCER BIOLOGY & THERAPY (2015)
Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
Alan Serrels et al.
CELL (2015)
TIGIT predominantly regulates the immune response via regulatory T cells
Sema Kurtulus et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
nCounter® PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA)
Alessandra Cesano
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston et al.
CANCER CELL (2014)
Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function
Christine Jean et al.
JOURNAL OF CELL BIOLOGY (2014)
FAK in cancer: mechanistic findings and clinical applications
Florian J. Sulzmaier et al.
NATURE REVIEWS CANCER (2014)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Development of a syngeneic mouse model for events related to ovarian cancer
KF Roby et al.
CARCINOGENESIS (2000)